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Gene regulationSeveral herpes simplex virus 1 microRNAs are encoded within or near the latency associated transcript (LAT)
locus, and are expressed abundantly during latency. Some of these microRNAs can repress the expression of
important viral proteins and are hypothesized to play important roles in establishing and/or maintaining
latent infections. We found that in lytically infected cells and in acutely infected mouse ganglia, expression of
LAT-encoded microRNAs was weak and unaffected by a deletion that includes the LAT promoter. In mouse
ganglia latently infected with wild type virus, the microRNAs accumulated to high levels, but deletions of the
LAT promoter markedly reduced expression of LAT-encoded microRNAs and also miR-H6, which is encoded
upstream of LAT and can repress expression of ICP4. Because these LAT deletion mutants establish and
maintain latent infections, these microRNAs are not essential for latency, at least in mouse trigeminal ganglia,
but may help promote it.oen).
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Herpes simplex virus (HSV) infections of mammalian hosts have
two distinct phases, productive (“lytic”) infection – which results in
abundant expression of N70 genes, viral replication, cell death, and
virus spread – and latent infection (reviewed in Roizman et al., 2007).
Following inoculation at a peripheral site, the virus lytically infects
epithelial cells, from which it gains access to nerve terminals. After
retrograde transport to neuronal cell bodies, the virus can initiate a
second round of lytic infection (acute ganglionic replication), and/or
establish a latent infection. Latent infection persists for the lifetime of
the host, and is the reservoir for recurrent HSV disease.
Lytic gene expression begins with the expression of immediate
early (α or IE) genes, whose transcription does not require the ex-
pression of any viral proteins. IE proteins such as ICP4 and ICP0 are
important for the expression of subsequent viral genes. IE gene ex-
pression is followed by the expression of early (β or E) genes, which
are required for viral DNA replication, and then the expression of late
(γ or L) genes, whose maximal transcription requires viral DNA
synthesis (Honess and Roizman, 1974). In contrast, latent infections
are characterized by the absence of infectious virus and little de-
tectable expression of IE, E, and L genes. The only abundantly
expressed locus encodes the latency-associated transcripts (LATs).In latently infected neurons, LATs include a low abundance
primary 8.3 kb polyadenylated transcript and highly abundant, stable
~2 kb and smaller intron species (Dobson et al., 1989; Farrell et al.,
1991; Krause et al., 1991; Spivack and Fraser, 1988) (Fig. 1E). During
lytic infection, only the ~2 kb LAT intron species is detected, it is much
less abundant than in latently infected cells, and its maximal
expression requires viral DNA synthesis (Krause et al., 1988; Spivack
and Fraser, 1987; Spivack and Fraser, 1988).
Several results point to products of the LAT locus functioning in
repression of lytic HSV gene expression, which would favor estab-
lishment and maintenance of latency. There is evidence that LAT can
repress lytic replication and IE gene expression in a neuronal cell line
(Mador et al., 1998). LAT deletion mutations increase lytic HSV gene
expression in acutely and latently infected mouse trigeminal ganglia
(Chen et al., 1997; Garber et al., 1997) (although there is a report to
the contrary in rabbit ganglia (Giordani et al., 2008)). Although there
is a report of the opposite effect (Kwiatkowski et al., 2009), we have
found that LAT deletions also result in decreased heterochromatin
marks on lytic gene promoters in latently infected mouse trigeminal
ganglia, so LAT has been proposed to silence viral gene expression as a
long non-coding RNA (Cliffe et al., 2009; Wang et al., 2005).
A second potential mechanism for repression of lytic gene ex-
pression during latency was uncovered with the discovery of HSV-
encoded microRNAs (miRNAs) in ganglia latently infected with either
HSV-1 or HSV-2 (Jurak et al., 2010; Tang et al., 2008, 2009; Umbach
et al., 2008, 2009, 2010). MiRNAs are ~22 nucleotide (nt) RNAs
derived from larger (~60–80 nt) hairpin precursors known as pre-
miRNAs, which are in turn derived from long primary transcripts (pri-
miRNAs) (reviewed in Bartel, 2004). MiRNAs speciﬁcally recognize
Fig. 1. Genetic elements in the HSV-1 long internal repeat. (A) Prototypic arrangement of the HSV-1 genome with the terminal and internal repeat regions (TRL, IRL, striped boxes;
IRS, TRS, solid boxes) bracketing long and short unique (UL, US, lines) regions. (B) IRL region expanded with genomic nt number in kb (K). (C) UL (open box)/IRL (gray band) junction,
IRL/IRS junction (L/S, open box), and start of IRS (gray band). (D) Protein coding transcripts from this region that encode UL56 (only 5′ end of transcript is shown), ICP0, and ICP34.5.
(E) LATs, including unstable 8.3 kb and 6.3 kbminor LATs and 2 kb and 1.5 stable LAT intron species. (F) L/ST RNA species. (G) Sites of miR-H1 throughmiR-H6 indicated with vertical
dotted lines and their directions indicated by open arrows. (H) Mutants used in this study, with deletions indicated by open boxes. (I) Sites of LAT PCR primers used in this study to
quantify LAT RNA. In (D), (E), and (F), transcripts are depicted with black lines with arrowheads indicating direction of transcription. For protein coding transcripts and stable LATs,
gray lines indicate sequences that are spliced out. In (E), (G), (H), and (I), locations are indicated in nucleotide number.
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degradation (Bartel, 2009). In transient transfection assays, one of the
HSV miRNAs found in latently infected ganglia, miR-H2 (for HSV-2,
also known as miR-III), can repress the expression of the important IE
protein ICP0 (Tang et al., 2009; Umbach et al., 2008), and a second
miRNA, HSV-1 miR-H6, can repress the expression of the essential IE
protein ICP4 (Umbach et al., 2008). Two others, miR-H3 and miR-H4
(for HSV-2, also known as miR-I and miR-II) can repress the ex-
pression of the L protein ICP34.5 in transient transfection assays (Tang
et al., 2008, 2009, I. Jurak, S. Lim, P.J. Yen, and D.M. Coen, unpublished
data). Four of the miRNAs found in latently infected ganglia (miR-H2–
miR-H5) could derive from the long, lower abundance LATs (Fig. 1),
and were detected in cells transfected with LAT expression plasmids
(Umbach et al., 2008; Tang et al., 2008, 2009). However, a ﬁfth miRNA
found in latently infected ganglia, HSV-1 miR-H6, was not detected in
cells transfected with the LAT transcription unit. This miRNA is
encoded upstream of the LAT promoter, on the opposite strand from
LAT transcribed sequences (Umbach et al., 2008) (Fig. 1G). The pri-
miRNA for HSV-1 miR-H6, and the sequences that control its ex-
pression have not been identiﬁed.
Because HSV-1 miR-H2–H4 and miR-H6 can repress the expres-
sion of proteins that are crucial for lytic gene expression and virus
production, we and others have hypothesized that these miRNAs play
important roles in establishing and/or maintaining latency (Moens,
2009; Tang et al., 2008; Umbach et al., 2008). On the other hand,
most LAT deletion mutants are able to establish and maintain latent
infections (Krause et al., 1995; Leib et al., 1989a; Perng et al., 1994;
Sedarati et al., 1989; Steiner et al., 1989; Thompson and Sawtell,
1997). We wondered whether LAT deletions actually affect the
expression of HSV-1 miRNAs, particularly miR-H6.
We therefore investigated the expression of HSV-1miRNAs encoded
within or near the LAT locus in cell culture and in acutely and latently
infected mouse ganglia. In particular, we wished to determine how theexpression of these miRNAs relates to HSV-1 LAT expression, including
whether LAT is the pri-miRNA in these settings for these miRNAs, as
proposed, and whether LATmutations affect the expression of miR-H6,
which is not in the LAT transcription unit. Our results have important
implications for the role(s) of miRNAs in latency.
Results and discussion
Kinetics of HSV-1 miRNA expression in cell culture
Wewished to evaluate the kinetics of expressionofHSV-1miR-H2–
H6 in lytically infected cells, and the relationship of the expression
of these miRNAs to LAT expression. We also assayed a sixth HSV-1
miRNA, miR-H1, which is encoded near the LAT locus (Cui et al., 2006;
Jurak et al., 2010). Using Northern blotting, we had previously shown
that in lytically infected cells HSV-1 miR-H1 and miR-H6 are abun-
dantly expressed, that the pre-miRNA for HSV-1 miR-H5 can be de-
tected, and that miR-H1 behaves as a late gene product (Cui et al.,
2006; Jurak et al., 2010). The expression of HSV-1 miRNAs in lytically
infected cells has also been assessed using reverse transcription-
polymerase chain reaction (RT-PCR), but either at only one time
point, 16 h.p.i., in which numbers of miRNAs per cell were measured
(Umbach et al., 2008), or at one or two time points (e.g. 6 and 18 h.p.i.),
in which relative increases in miRNA were measured (Umbach et al.,
2009).
As a ﬁrst step, we performed Northern blot hybridization of short-
enriched (S) RNA (b200 nt) from Vero cells infected with HSV-1 wild
type (wt) strain KOS for times ranging from two to 18 h.p.i. on two
separate blots (Figs. 2A and B). Use of S RNA allowed us to run the
equivalent of 70 to 100 μg total RNA per lane, to increase the sen-
sitivity of detection. Both blots were sequentially probed, stripped and
re-probed. The cellular miRNA, let-7a, served as both a cellular and a
loading control (bottom panels, Figs. 2A,B), and showed no change
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2006). For all the HSV-1miRNAs shown in Figs. 2A and B, and for miR-
H5 (Fig. 2D; Cui et al., 2006; Jurak et al., 2010 and data not shown),
~60 nt hybridizing RNA species, which we infer are pre-miRNAs,
could be detected. All but pre-miR-H3 were not detected until at least
8 h.p.i., consistent with late kinetics (Figs. 2A and B, and data not
shown). As previously observed (Cui et al., 2006; Jurak et al., 2010),
mature miRNAs were detected for miR-H1 and miR-H6 (Figs. 2A, B).
We also detected reproducibly, albeit very weakly, mature miR-H2 at18 h.p.i. (Fig. 2A, second panel from top). (Although we appeared
to detect miR-H2 at 4 h.p.i. in Fig. 2A, this result could not be
reproduced.) Similar to previous results with HSV miRNAs (Cui et al.,
2006; Jurak et al., 2010; Tang et al., 2008, 2009), in all cases the
mature miRNAs were substantially less abundant than the pre-
miRNAs (Figs. 2A and B). As discussed previously (Cui et al., 2006),
this might be due to HSV interfering with miRNA biogenesis or
stability, which would be consistent with HSV-1 suppression of RNA-
induced gene silencing (Wu et al., 2009). Alternatively, HSV pre-
miRNAs might be poor substrates for Dicer, or HSV miRNAs might be
relatively unstable.
In the presence of the protein synthesis inhibitor cycloheximide
(Chx) or the viral DNA synthesis inhibitor acyclovir (ACV), pre-miR-
H1, -H2, -H4-5p, and -H6 and mature miR-H1 (as previously reported
(Cui et al., 2006)), -H2, and -H6 were not detectable (Figs. 2A and B).
Thus, these RNAs behave as late gene products by both time course
and inhibitor criteria.
In contrast to the other HSV-1 pre-miRNAs, pre-miR-H3 was
evident at 2 h.p.i. Its abundance remained relatively constant through
8 h.p.i., and then increased between 8 and 18 h.p.i. (Figs. 2A, B). At no
time was mature miR-H3 detectable. Interestingly, the abundance of
pre-miR-H3 was enhanced at 8 h.p.i. in the presence of Chx. Thus, by
both time course and inhibitor criteria, this pre-miRNA behaves as an
immediate early gene product. Perhaps this pre-miRNA is expressed
from an IE promoter calledαX that is negatively regulated by ICP4 and
drives the expression of transcripts known as L/STs (Bohenzky et al.,
1993, 1995; Yeh and Schaffer, 1993; Fig. 1). Pre-miR-H4 and pre-miR-
H5 could also be derived from L/STs, yet we did not detect IE kinetics
for these pre-miRNAs. Differential primary RNA secondary structure,
differential utilization of the miRNA biogenesis machinery, or dif-
ferential effects on degradation of the pri-miRNA following excision of
pre-miR-H3 may help explain this observation. More study of the
biogenesis of these pre-miRNAs is needed.
Consistent with the increase in abundance between 8 and 18 h.p.i.,
ACV reduced the abundance of pre-miR-H3. This result suggests that
pre-miR-H3 accumulates through late times, as is true for certain
other IE RNAs such as ICP0mRNA (Weinheimer and McKnight, 1987).
HSV-1 miRNAs are expressed from a LAT mutant during lytic infection
HSV-1 miR-H2 through miR-H5 are encoded within the 8 kb LAT
transcription unit and are expressed in cells transfected with plasmids
encoding full-length LAT (Umbach et al., 2008) (Fig. 1E). To investigate
whether these miRNAs are derived from LATs during lytic infection,
Vero cells were infected with wt strain KOS, a KOS-derived deletion
mutant, KdlLAT, which lacks the LAT promoter and ~1.8 kbp of LAT
coding sequences, and a marker-rescued derivative of KdlLAT, KFSLAT
(Fig. 1H; Garber et al., 1997). At 16 h.p.i., S RNA was isolated and
analyzed by Northern blot hybridization (Figs. 2C and D). Roughly
equal amounts ofmature let-7aweredetected in each sample (Figs. 2C,
D, bottom panels). Moreover, similar amounts of pre-miRNAs and
mature miRNAs for miR-H1, miR-H2 and miR-H6 and pre-miRNAs forFig. 2. Northern blot analysis of HSV-1 pre-miRNAs and mature miRNAs in lytically
infected cells. S RNAs harvested from mock- or HSV-infected cells were separated by
polyacrylamide gel electrophoresis, transferred to nylon membranes, and probed with
miRNA-speciﬁc end-labeled 32P oligonucleotides, as indicated to the left of each panel.
Each blot was stripped, exposed to ﬁlm to verify that stripping was complete, and re-
probed multiple times. Different intensities of end-labeled 32P molecular weight
markers indicate the relative order of probing. The sizes of molecular weight markers
are indicated with tick marks to the right of each panel. (A and B) Time course of
infection. Mock-infected (0) or HSV-1 infected cell RNA at 2, 4, 8, and 18 h.p.i.; ACV,
cells infected in the presence of acyclovir and harvested at 18 h.p.i.; Chx, cells infected
in the presence of cycloheximide and harvested at 8 h.p.i. Decade, Decade Marker
(Ambion). (C and D) Effect of LAT deletion. Cells were mock-infected (Mock) or infected
with wt HSV-1 strain KOS, LAT deletion mutant KdlLAT1.8, or its rescued derivative,
KFSLAT, and harvested at 16 h.p.i. ϕX174, ϕX174 HinfI molecular weight marker.
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wt KOS, KdlLAT, and KFSLAT, with any minor differences among the
samples correlating with similar differences in the amounts of let-7a,
indicative of differences in loading. Thus, accumulation of these pre-
miRNAs and miRNAs during lytic infection is independent of the LAT
promoter.Quantitative RT-PCR analysis of miRNA expression during lytic infection
To analyze miRNA expression during lytic infection more quantita-
tively, we performed stem–loop quantitative RT-PCR (RT-qPCR)
analysis of RNA from Vero cells infected with HSV-1 strain KOS for
times ranging from two to 18 h.p.i. in the presence or absence of ACV.
Because pre-miRNAs are much more abundant than mature miRNAs
(Fig. 2), b40 nt RNA species were isolated to prevent pre-miRNAs and
larger transcripts from contributing to the RT-qPCR measurements.
(Such larger species are detected by this technique, albeit less efﬁciently
(Chen et al., 2005; M.F.K., unpublished results)). We assayed both
strands (5p and 3p) generated from pre-miR-H4, because they are
similar in abundance. Cellular let-7amiRNAwas quantiﬁed to normalize
recovery. Background values for the stem–loop RT-qPCR assays ranged
from ~0.1–~10 molecules per cell, depending on the miRNA assayed
(shown as zero time points in Fig. 3). We caution that stem–loop RT-Fig. 3. RT-PCR analysis of miRNAs and LAT in HSV-1 infected Vero cells. Vero cells were
infected with wt HSV-1 without (ﬁlled circles, solid line) or with (open circles, dashed
line) 200 μM ACV. MiRNA values were normalized to let-7a, and LAT values were
normalized to ng total RNA, and are presented as numeric means±standard deviation
(n=3) ofmolecules per cell plotted against h.p.i. (A)miR-H1; (B)miR-H2; (C) miR-H3;
(D) miR-H4-3p; (E) miR-H4-5p; (F) miR-H5; (G) miR-H6; (H) LAT.qPCR assays may underestimate the abundance of certain miRNAs,
especially if there is heterogeneity inmiRNA5′ and 3′ ends. Results from
three independent experiments were pooled (Fig. 3).
Using this more sensitive technique, some of the miRNAs, inc-
ludingmiR-H1,mir-H4-3p, andmiR-H6, could be detected as early as 2
or 4 h.p.i. Consistent with our Northern blot analyses and our previous
results (Fig. 2 and Umbach et al., 2008), miR-H1 and miR-H6 accumu-
lated throughout infection andwere substantiallymore abundant than
the other HSV-1 miRNAs (Figs. 3A and G). In this analysis, we found
~300 and ~4000 molecules/cell of miR-H1 and miR-H6, respectively,
which differ from our previously reported values of ~1200 and ~300
molecules/cell, respectively (Umbach et al., 2008). These differences
likely stem from changes to our assays (Supplemental materials and
methods) and experimental variability. ACV reduced the expression of
miR-H1 and miR-H6 ~10-fold. Thus, based on the Northern blot and
qRT-PCR results, the unknown pri-miRNA for miR-H6 during produc-
tive infection behaves as a late transcript.
miR-H2, miR-H4-3p, miR-H4-5p, and miR-H5, accumulated to ~30
molecules/cell, andmiR-H3 to less than 1molecule/cell. That might be
interpreted to mean that these miRNAs would be less likely to exert
meaningful effects on their targets. However, expression of both
strands of miR-H4 was relatively high at 2 and 4 h.p.i., at which times
the abundance of the L ICP34.5mRNA is relatively low. The expression
of miR-H2–miR-H5 exhibited varying degrees of sensitivity to ACV,
ranging from ~10-fold for miR-H2 to ~2-fold (if any) for miR-H3
(although this apparent lack of sensitivity to ACV may merely reﬂect
difﬁculties in quantifying this poorly expressed miRNA.) Thus, the RT-
qPCR and Northern blot analyses identify all of the miRNAs except
pre- and mature miR-H3 as late gene products.
To compare the expression of the miRNAs to that of LAT, total RNA
from which the b40 nt RNA had been isolated was assayed for
LAT intron species. LAT accumulated to much higher levels (~1000
molecules/cell) than any of the miRNAs encoded within the LAT
transcription unit, and its expression exhibited more sensitivity to ACV
(about 30-fold) than did any of the miRNAs.
Thus, based on differential ACV sensitivity (Fig. 3), and, more im-
portantly on the lack of effect of the LAT deletion (Fig. 2), transcripts
other than LATs serve as pri-miRNAs for HSV-1miR-H2–miR-H5 during
lytic infection, even though these miRNAs are encoded within the LAT
transcription unit. The pri-miRNAs appear to be late transcripts, except
for pri-miR-H3. During HSV infection, many long transcripts appear to
arise from inefﬁcient polyadenylation/cleavage (e.g. Holland et al.,
1984). Any number of such transcripts that originate upstream of LATs,
including those from promoters of transcripts described by Singh and
Wagner (1993) and Zhu et al. (1999) that we have suggested might
serve as pri-miRNAs for miR-H1 (Cui et al., 2006), might also serve as
pri-miRNAs for miR-H2–miR-H5 during productive infection.
Low expression of miRNAs during acute infection of mouse ganglia
We next investigated the expression of HSV-1 miR-H1–miR-H6
during acute ganglionic infection in two independent experiments.
Mice were inoculated on the cornea with wt strain KOS, LAT mutant
virus dlLAT1.8, which contains the same 1.8 kb deletion as KdlLAT, and
its marker rescued derivative, FSLAT (Leib et al., 1989a) (Fig. 1H). At
three days p.i., at which time titers of infectious virus are maximal
(Leib et al., 1989b), HSV-1 DNA was measured using qPCR and nor-
malized to mouse DNA. HSV-1 miRNAs were quantiﬁed from b40 nt
RNAs with stem–loop RT-qPCR and normalized to cellular let7a
(4.4×109 copies/ganglion). Although amounts of viral DNA were
different between experiments, within each experiment amounts of
wt and mutant DNA were similar (Supplemental Table 1).
The levels of HSV-1 miRNAs in ganglia acutely infected with KOS
were more than 3 orders of magnitude lower than those of let7a,
with no more than 3×106 copies/ganglion on average (data from one
of the two experiments are provided in Table 1; similar results were
Table 1
Levels of HSV-1 miRNAs in acutely and latently infected mouse trigeminal ganglia.
miR-H1 miR-H2 miR-H3 miR-H4-3p miR-H4-5p miR-H5 miR-H6
Acute 5.5±0.3 6.5±0.4 * 5.3±0.4 5.0±0.2 5.4±0.05 6.3±0.1
Latent * 7.8±0.1 * 8.7±0.1 7.4±0.5 8.5±0.09 8.0±0.5
L/A N/A 19 N/A 2400 260 1300 52
Levels of HSV-1miRNAs in trigeminal ganglia ofmice infectedwithwt strain KOS at 3 (acute, n=2) or 30 (latent, n=3) days after infection, expressed as log10meanmolecules per ganglion±
standarddeviation. L/A, ratio ofmean levels ofmiRNA in latently infected ganglia to those in acutely infected ganglia (numeric). Thedifferences in levels ofmiR-H2, -H4-3p, -H4-5p, -H5, and -H6
between acutely infected and latently infected ganglia were statistically signiﬁcant (p≤0.0202, two-sided t test).
*Not detectable above background. N/A, does not apply.
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miRNAs, miR-H3, above background levels. The miRNA levels were
also very low on a per viral DNA basis; no miRNA was present in
ganglia acutely infected with KOS at N2 copies/viral genome (Fig. 4).
There were no signiﬁcant differences between the levels of the
miRNAs per viral genome in ganglia acutely infected with KOS and
those in ganglia infected with dlLAT1.8 (Fig. 4). Thus, averaged over
the entire ganglion, at the peak of ganglionic replication during acute
infection of mice, expression of these miRNAs was weak, and as
was true during lytic infection in cell culture, independent of the LAT
promoter.
However, some infected cells in acutely infected ganglia do not
undergo lytic infection, but rather enter the latent program of gene
expression and thus contain only low levels of HSV DNA (Simmons
et al., 1992). In these cells, the amounts of miRNAs are likely to be
relatively high per viral genome. This might be even more likely after
day 3 p.i. (see below), and thus the miRNAs would be much more
likely to exert effects on targetmRNAs. In particular, miRNAs targeting
ICP4 and ICP0 mRNA should result in reductions in the subsequent
expression of IE and early proteins, favoring entry into latency.
Indeed, miRNA levels in acutely infected cells might set a threshold:
when IE mRNAs are expressed below this threshold, latency would be
more likely to be established; when IE mRNAs rise above this
threshold, productive infection would be more likely to ensue.
Expression of HSV-1 miRNAs during latent infection
We next investigated the expression of HSV-1 miR-H1–miR-H6
using stem–loop RT-qPCR in trigeminal ganglia infectedwithwt strain
KOS at 30 days p.i. We were unable to detect miR-H3 above back-Fig. 4. A LAT deletion does not affect expression of HSV-1 miRNAs in acutely infected
mouse ganglia: In two independent experiments, mice were infected with wt HSV-1
strain KOS (darkest bars), mutant dlLAT1.8 (lightest bars), or rescued derivative, FSLAT
(intermediate bars). At 3 days p.i., ganglia were harvested and analyzed for eachmiRNA
indicated below the graph, and for viral DNA. The amounts of eachmiRNA per viral DNA
are presented. Each bar represents the log10 mean; error bars indicate standard
deviations. No signiﬁcant differences were observed between themutant and either the
wt or rescued derivative using one way ANOVA with Bonferroni post-tests applied to
each miRNA.ground values in these studies (data not shown). We note that miR-
H3 has been detected much more abundantly in deep sequencing
analyses of latently infected mouse and human ganglia than in
productively infected cells (Jurak et al., 2010; Umbach et al., 2008,
2009). Thus, we consider our inability here to detect miR-H3 above
background in latently infected ganglia to be a shortcoming of the RT-
qPCR assay. We were also unable to detect HSV-1 miR-H1 above
background values, but its levels were at least ten-fold lower than
those of the other miRNAs (data not shown).We therefore focused on
those miRNAs: HSV-1 miR-H2, miR-H4-5p, miR-H4-3p, miR-H5, and
miR-H6.
In one experiment, we compared levels of these miRNAs to
amounts of viral DNA (log10 mean of 4.8±0.5 molecules/ganglion),
using qPCR, and amounts of stable LAT, using qRT-PCR (log10 mean of
7.7±0.2 molecules/ganglion). In this experiment, there were roughly
20 to 200 of these miRNAs per viral genome in latently infected
ganglia (Table 2). Moreover, expression was relatively consistent
from ganglion to ganglion (results not shown), in contrast to lytic
transcripts that have been detected in latently infected ganglia (Chen
et al., 1997, 2002; Feldman et al., 2002; Kramer and Coen, 1995; Pesola
et al., 2005). These miRNAs were expressed at levels ranging from 2%
to 20% those of stable LAT (Table 2). The reduced amounts of miRNAs
relative to LATs could reﬂect inefﬁcient processing of the miRNAs
from the pri- and pre-miRNAs, or reduced stability of the miRNAs
relative to stable LAT. Regardless, the abundance and consistent
expression of these miRNAs during latency indicate that they are truly
latent transcripts — and perhaps should be considered LATs.
In one of the two experiments in which we had examined miRNA
expression in acutely infected ganglia, we compared the amounts of
HSV-1 miRNAs in acutely infected and latently infected ganglia
(Table 1). In this experiment, there was substantially (19- to 2400-
fold) more of miR-H2 and miR-H4–miR-H6 per ganglion in latently
infected ganglia than in acutely infected ganglia, and these differences
were statistically signiﬁcant (Table 1). This substantial increase in
miRNA levels between 3 days p.i. and 30 days p.i. differs from the
similar levels of LAT at the two time points (Kramer et al., 1998). This
difference may reﬂect relatively slow processing of the miRNAs from
their pri- and pre-miRNAs. It also suggests that the levels of miRNAs
and thus the probability that they exert repressive effects increase
after 3 days p.i.
Effects of LAT mutations on miRNA expression during latent infection
We next addressed the effect of the 1.8 kbp LAT deletion in mutant
dlLAT1.8 on expression of the HSV-1 miRNAs in latently infected
ganglia. We inoculated mice via the corneal route with dlLAT1.8, its
rescued derivative, FSLAT, or wt strain KOS, and analyzed ganglia
30 days p.i. for DNA by qPCR and for miRNAs by stem–loop RT-qPCR.
Three independent experiments were performed, and the results
were pooled (Supplemental Table 1 and Fig. 5A). Similar to our pre-
vious ﬁndings using older PCR methods (Chen et al., 1997, 2000,
2002) and with recent studies of LAT mutants in mice that used real-
time methods (Hoshino et al., 2009), we found similar amounts of
DNA (~3×104 molecules/ganglion) in ganglia latently infected with
wild type, mutant, and marker rescued viruses (Supplemental Table
Table 2
Levels of HSV-1 miRNAs relative to LAT and viral DNA in latently infected mouse
trigeminal ganglia.
miR-H2 miR-H4-3p miR-H4-5p miR-H5 miR-H6
miRNA/vDNA 170 130 19 19 54
miRNA/LAT 0.20 0.14 0.022 0.021 0.060
Mean numbers of miRNAs per viral genome (vDNA) or LAT in trigeminal ganglia from
mice infected with HSV-1 wt strain KOS (n=4).
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and mouse strains where less viral DNA was found in LAT mutant-
infected ganglia, but does not preclude there being fewer latently
infected neurons in LATmutant-infected ganglia as found in that study
(Thompson and Sawtell, 2001). The amounts per viral genome ofmiR-
H2, miR-H4-5p, miR-H4-3p, miR-H5, and miR-H6 were markedly
reduced in ganglia latently infected with the LAT mutation, dlLAT1.8,
relative to ganglia infected with either the wt or the rescued
derivative (Fig. 5A). The reductions ranged from 500- to 900-fold,
and were statistically signiﬁcant, except for the difference in miR-H4-
5p between dlLAT1.8 and KOS (Fig. 5A). Indeed, the levels of these
miRNAs in dlLAT1.8-infected ganglia were not distinguishable from
background (one way ANOVA with Bonferroni post-tests). Similar
results were obtained using a different mutant, KdlLAT, containing
the 1.8 kbp LAT deletion (Garber et al., 1997), and its marker rescued
derivative (not shown). Thus, the 1.8 kbp LAT deletion essentially
abolishes the expression of these miRNAs.
The dramatic reductions of miR-H2 and miR-H4–miR-H6 in
dlLAT1.8-infected ganglia could have been due to the loss of se-
quences downstream of the LAT promoter (Fig. 1). To address this, we
conducted an experiment comparing the expression of these miRNAs
from wt strain KOS, mutant KOSΔPstLAT, and its marker-rescued
derivative PstRLAT. KOSΔPstLAT contains a ~200 bp deletion that
includes the LAT promoter, leaving almost the entire 8 kb LAT
transcribed sequence intact (Cliffe et al., 2009; Fig. 1H). This deletion,
like the 1.8 kb deletion of dlLAT1.8, reduces LAT expression by at least
three orders of magnitude (Chen et al., 1997; Cliffe et al., 2009). Our
results with KOSΔPstLAT (Fig. 5B) were very similar to those with
dlLAT1.8 (Fig. 5A). In ganglia latently infected with KOSΔPstLAT, there
weremarked (N100-fold) and signiﬁcant reductions in the levels of allFig. 5. LAT deletions markedly reduce the expression of HSV-1 miRNAs in latently infected
strain KOS (blue bars), mutant dlLAT1.8 (red bars in (A)) or PstΔLAT (red bars in (B)), or resc
ganglia were harvested and analyzed for each miRNA indicated below the graphs, and for vira
in parentheses under the graph. The amounts of each miRNA per viral DNA are presented
signiﬁcant differences (**, pb0.001) and signiﬁcant differences (*, pb0.05) between mutant
with Bonferroni post-tests applied to each miRNA.of these miRNAs relative to the wt virus and the rescued derivative
(Fig. 5B). None of the amounts of HSV-1 miRNAs in ganglia latently
infected with KOSΔPstLAT was signiﬁcantly higher than background
(one way ANOVA with Bonferroni post-tests).
Thus, the 200 bp sequence that contains the LAT promoter is nec-
essary for the expression of miR-H2 and miR-H4–miR-H6. This result
combined with the result that HSV-1 miR-H2 through miR-H5 can be
expressed from a plasmid with the LAT transcription unit driven
by a heterologous promoter (Umbach et al., 2008) provides strong
evidence that LAT is the pri-miRNA for these miRNAs. LAT is also
highly likely, then, to be the pri-miRNA for HSV-1 miR-H7 and miR-
H8, which are encoded within the LAT transcription unit and have
been detected in latently infected mouse and human ganglia (Jurak
et al., 2010; Umbach et al., 2009, 2010).
More surprising was our ﬁnding that a 200 bp deletion that in-
cludes the LAT promoter drastically reduces expression of miR-H6
(Fig. 5B). The simplest interpretation of this result is that a crucial
segment of the promoter for the miR-H6 pri-miRNA lies within those
200 bp. An intriguing possibility is that this promoter and the LAT
promoter are identical. Recently, many eukaryotic promoters have
been shown to mediate bidirectional transcription (reviewed in
Beretta and Morillon, 2009; Jacquier, 2009). On the other hand, it is
possible that the promoter for pri-miR-H6 is within LAT transcribed
sequences, but the LAT promoter deletion somehow reduces pri-
miR-H6 expression. Consistent with this possibility, the 5′ end of a
transcript that could serve as the pri-miRNA for miR-H6 maps
within the LAT 5′ exon, outside of the sequences deleted in
KOSΔPstLAT (D.C. Bloom, personal communication). Other interpre-
tations such as LAT expression being required for miR-H6 expression
are less likely, but cannot currently be excluded.
Similarities and differences with HSV-2
It is interesting to compare our results onHSV-1miRNAswith similar
studies of HSV-2 miRNAs. Our conclusion that HSV-1 miR-H2–miR-H5
in lytically infected cells derivemainly froma pri-miRNA other than LAT
is similar to the conclusion reachedbyTanget al. (2008, 2009) forHSV-2
miR-H2–miR-H4 (also known as miR-III, I, and II, respectively). In a
paper that appearedwhile this manuscript was being completed, it was
reported that HSV-2 miR-H6 expression in cell culture was unaffected
by a 0.6 kbp deletion of LAT promoter and ﬁrst exon sequences (Tangmouse ganglia. In three independent experiments, mice were infected with wt HSV-1
ued derivatives, FSLAT (green bars in (A)) or PstRLAT (green bars in (B)). At 30 days p.i.,
l DNA. The numbers of ganglia infected with each virus that were analyzed are provided
. Each bar represents the log10 mean; error bars indicate standard deviations. Highly
and wt or mutant rescued derivatives are indicated as determined by one way ANOVA
245M.F. Kramer et al. / Virology 417 (2011) 239–247et al., 2011), similar to our ﬁndings with a larger LAT deletion. Our
ﬁnding that a 200 bp deletion of the LAT promoter or a larger LAT
deletion drastically impairs expression of HSV-1 miR-H2, and miR-H4–
miR-H6 in latently infected cells is similar to the effect of the larger
0.6 kbp deletion of LAT promoter and ﬁrst exon sequences on HSV-2
miR-H3 (miR-I) (Tang et al., 2008), and HSV-2 miR-H6 (Tang et al.,
2011). However, in contrast to our ﬁnding that LAT deletions had little
effect on expression ofHSV-1miRNAs in acutely infectedmouse ganglia,
Tang et al. reported that the expression of HSV-2 miR-H3 and miR-H6
was drastically reduced by the 0.6 kbp deletion in acutely infected
guinea pig ganglia (Tang et al., 2008, 2011). Moreover, inspection of
data in these studies (Tang et al., 2008) reveals 2- to 3-fold higher
amounts of HSV-2 miR-H3 (miR-I) than LAT in guinea pig ganglia
latently infected with HSV-2, and similar amounts of HSV-2 miR-H3
and miR-H6 in acutely and latently infected ganglia. In contrast, we
found that the HSV-1 miRNAs were at least ﬁve-fold less abundant
than LAT in mouse ganglia latently infected with HSV-1, and we found
much lower levels of the miRNAs in acutely infected ganglia. Some of
the differences among the studies might be due to technical issues.
These issues could include when acute ganglionic infection was
assayed (day 3 for mice and day 8 for guinea pigs), that HSV-2
miRNA levels were measured from total RNA using an assay that may
have also detected pri-miRNAs and pre-miRNAs, or the possibility that
our stem–loop RT-qPCR assays somehow considerably underestimated
miRNA abundance. Alternatively, some of the discrepancies among the
studies might reﬂect interesting differences between HSV-1 and HSV-2
and/or between mouse and guinea pig.Implications for HSV latency
Because HSV-1 miR-H6 is encoded upstream of LAT and is able to
repress ICP4 expression in transient transfection assays (Umbach
et al., 2008), we wondered whether HSV LAT deletionmutants such as
dlLAT1.8 might express this miRNA, thus explaining why these
mutants are able to establish and maintain latent infections, at least
qualitatively (Krause et al., 1995; Leib et al., 1989a; Perng et al., 1994;
Sedarati et al., 1989; Steiner et al., 1989; Thompson and Sawtell,
1997). However, we found that suchmutants are also highly defective
for miR-H6 expression, as well as for miRNAs encoded within LAT
transcribed sequences. Thus, the miRNAs expressed abundantly
during latency are not necessary for establishment and maintenance
of latent infections, at least in mice. On the other hand, the defect of
HSV-1 LAT mutants for miRNA expression can help explain why such
mutants exhibit reduced repression of productive cycle genes during
acute and latent ganglionic infection (Chen et al., 1997, 2002; Garber
et al., 1997). Additionally, LAT mutants are defective for chromatin-
mediated transcriptional silencing (Cliffe et al., 2009; Wang et al.,
2005) (although one study differed (Kwiatkowski et al., 2009)), which
may be a second repressive LAT function. Why then are these mutants
able to establish and maintain latent infections in mice? One
possibility is that other factors such as innate immunity (e.g. Leib
et al., 1999), the repressive effects of immune cells in ganglia (e.g.
Knickelbein et al., 2008), or the neuronal environment (e.g. Kristie
et al., 1999) are sufﬁcient for establishment and maintenance of
latency. Another possibility is that while certain of the miRNAs
affected by the LAT mutations might be necessary for repression of
lytic gene expression and thus latency, others might exert opposite
effects, perhaps keeping the latent virus poised for reactivation.
Studies of mutations that affect individual miRNAs should help
address this possibility. A ﬁnal consideration is that in humans, unlike
in mice, spontaneous reactivation of HSV is frequent (Margolis et al.,
2007; Mark et al., 2008; Schiffer et al., 2009). It is possible that
interference with LAT functions, including miRNAs (e.g. by oligonu-
cleotides that antagonize miRNAs), could have a greater effect in
humans, and thus disrupt latency.Materials and methods
Viruses and cells
Viruses used in this study were HSV-1 strain KOS and mutants
derived from KOS: dlLAT1.8 and its marker-rescued derivative FSLAT
(Leib et al., 1989a), KdlLAT and its marker-rescued derivative KFSLAT
(Garber et al., 1997) and KOSΔPstLAT and its marker-rescued
derivative PstRLAT (Cliffe et al., 2009). Viruses were propagated and
titrated on Vero cells, as previously described (Leib et al., 1989a).
Northern blot analysis
Vero cells were mock-infected or infected with HSV-1 strain KOS,
KdlLAT, or KFSLAT at a multiplicity of infection (MOI) of 10. At various
times post infection, cells were harvested, and S RNA (≤200 nt) was
isolated using the mirVana kit (Ambion) per the manufacturer's
instructions. In preliminary experiments, we quantiﬁed total RNA,
isolated with the same kit, and S RNA spectrophotometrically
(NanoDrop) and determined that S RNA represented 10% and 14% of
total RNA in trigeminal ganglia and Vero cells, respectively (data not
shown). Up to 10 μg of Vero cell S RNA was resolved by polyacryl-
amide gel electrophoresis on a 15% gel, transferred to a positively-
charged nylon membrane (BrightStar-Plus, Ambion), and UV-cross-
linked using a Stratagene UV Crosslinker on the auto crosslinking
setting (120,000 μJ/cm2). DNA oligonucleotides complementary to
each miRNA of interest were obtained from IDT (sequences provided
in Supplemental Table 2) and end-labeled with [γ-32P]-ATP. Hybrid-
ization with the labeled oligonucleotides, washes, and radiographic
detection were performed as described previously (Cui et al., 2006).
Animal procedures and tissue acquisition
Male CD-1 mice obtained from Charles River Laboratories were
housed in accordance with institutional and NIH guidelines on the
care and use of animals in research, with procedures approved by the
Institutional Animal Care and Use Committee of Harvard Medical
School. HSV (2×106 PFU in 3 μL per eye) or cell culture media was
inoculated onto scariﬁed corneas of 7 week old mice, as described
previously (Kramer and Coen, 1995). At three (acute) or thirty
(latent) days post infection, mice were sacriﬁced humanely, and the
trigeminal ganglia were rapidly harvested onto dry ice or into liquid
N2, and stored at −80 °C as described previously (Kramer and Coen,
1995).
qPCR and qRT-PCR
In describing our real-time PCR experiments, we conform to
guidelines that have been designated minimum information for
publication of quantitative real-time PCR experiments (MIQE; Bustin
et al., 2009). Hownucleic acidswere prepared and assessed for quality,
our choices for reference gene, assay design and validation, reagents
and instruments, and data analysis for stem–loop RT-qPCR are detailed
in Supplemental materials and methods. Brieﬂy, viral (tk gene) and
reference (cellular single-copy adipsin gene) DNA were quantiﬁed by
qPCR as described previously (Pesola et al., 2005), but with mouse
adipsin rather than GAPDH as the cellular gene (sequences provided in
Supplemental Table 3). LATwas quantiﬁed by RT-qPCR from total RNA
samples using RT-qPCR procedures described previously for other
genes (Kramer et al., 2003) (sequences provided in Supplemental
Table 3). LAT was normalized to ng total RNA, and copies per cell were
calculated from experimentally determined total RNA content. Total
RNA content in Vero cells, which we experimentally determined to be
19.2 pg total RNA/cell, was ascertained by extraction of total RNA from
known numbers of Vero cells counted using a hemocytometer, and
quantiﬁed spectrophotometrically (NanoDrop). Stem–loop RT-qPCR
246 M.F. Kramer et al. / Virology 417 (2011) 239–247assays (Chen et al., 2005) to quantify host and viral miRNAs were
extensively modiﬁed from those originally described (Umbach et al.,
2008) to optimize detection and quantiﬁcation and reduce back-
ground. These modiﬁcations are detailed in Supplemental materials
andmethods. Brieﬂy, b40 nt RNAwas assayed for viralmiRNAs and for
let7-a, which served as a normalization control.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.virol.2011.06.027.
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